The Readout Loud
Episode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron?
Senior writer Helen Branswell joins us to discuss the latest twists in the pandemic, including rising case counts, next-generation vaccines, and the latest data from pediatric trials. We also dive into the latest news in the life sciences, including Moderna's grand ambitions, Al Sandrock's new job, and the next big FDA debate.